For those keeping tabs on gut health, probiotics and fiber are likely familiar topics. You may have experimented with various supplements, switched to sourdough, or perhaps made sauerkraut a staple in your grocery list. These choices are a step in the right direction, but recent scientific advancements in gut health are unveiling new possibilities, particularly through an unexpected resource—human breast milk.
Two bioactive components inherent to breast milk—Human Milk Oligosaccharides (HMOs) and lactoferrin—are increasingly capturing the attention of researchers. Traditionally recognized as vital for infant growth, these compounds are now under examination for their exceptional abilities to promote gut health, bolster immunity, and restore microbial equilibrium in adults. For the first time, they have been combined into a single supplement.
Understanding Human Milk Oligosaccharides (HMOs)
Human Milk Oligosaccharides represent complex carbohydrates that rank as the third most prevalent solid constituent in breast milk, trailing only lactose and fats. With over 200 unique HMO structures, what makes them intriguing is their complete indigestibility by infants—newborns cannot break them down. So, why does the body exert such effort to synthesize them?
The answer boils down to gut microbiome health. HMOs pass through the digestive tract undigested and reach the large intestine, where they provide a selective source of nourishment for beneficial bacteria, notably species like Bifidobacterium. Unlike conventional prebiotics, such as inulin or fructo-oligosaccharides (FOS), which can promote a wider array of gut bacteria—including some potentially harmful strains—HMOs specifically target and feed beneficial organisms (Elison et al., 2016).
The significance of this selectivity is profound. In a pivotal randomized controlled trial involving 100 healthy adults, supplementation with the HMO 2’-fucosyllactose (2’-FL) resulted in substantial increases in Bifidobacterium populations, alongside a decrease in potentially harmful Proteobacteria, all happening within a mere fortnight. The study also confirmed that doses of HMO supplementation up to 20 grams per day were both safe and well tolerated (Elison et al., 2016).
HMOs: Beyond the Microbiome
The advantages of HMOs go further than merely feeding beneficial bacteria. Advanced gut simulation studies reveal that HMOs contribute to fortifying the intestinal barrier—the vital lining that segregates what exists in your gut from the rest of your body. When this barrier is compromised, often referred to as “leaky gut,” it can instigate systemic inflammation and immune dysfunction (Šuligoj et al., 2020).
Moreover, HMOs have been shown to modulate inflammatory responses directly. Research published in mBio in 2024 indicated that oral supplementation with 2’-FL significantly diminished markers of intestinal inflammation in experimental models of inflammatory bowel diseases, aiding in the restoration of microbial balance and the protection of the gut lining (Schalich et al., 2024).
This dual functionality—selectively feeding beneficial bacteria while concurrently enhancing the gut barrier and reducing inflammation—distinguishes HMOs from standard prebiotics. Consequently, researchers are increasingly recognizing them not merely as infant nutrition but as a potent asset for adult gut health.
Introducing Lactoferrin: The Immune Shield
The other significant bioactive from breast milk is lactoferrin, an iron-binding glycoprotein that plays a key role in innate immunity. Found predominantly in colostrum (the initial milk produced after birth), lactoferrin is also present in tears, saliva, and nasal secretions—essentially manifesting wherever immediate immune defense is required.
Lactoferrin’s remarkable versatility is key to its efficacy. It exhibits antimicrobial, antiviral, anti-inflammatory, and immunomodulatory functions. As noted in a comprehensive review by Legrand (2016), lactoferrin is regarded as “the most polyvalent protein present in host defence,” capable of both activating immune cells when threats arise and soothing excessive inflammation once the danger has subsided (Legrand, 2016).
Within the digestive tract, lactoferrin underpins the integrity of the intestinal barrier, helps balance beneficial and harmful bacteria, and facilitates healthy iron absorption while not supporting pathogenic organisms. Research ensures that lactoferrin enhances tight junction protein expression in the intestinal lining—these are the molecular “seals” between cells that avert unwanted substances from penetrating (Ochoa & Sizonenko, 2017).
Historically, supplemental lactoferrin has been sourced exclusively from bovine milk. Although bovine lactoferrin shares certain structural features with its human counterpart, they are not identical. Now, a new generation of recombinant human lactoferrin (known as effera™) is created via precision fermentation, resulting in a molecule that mirrors the lactoferrin found in human breast milk. This marks a major step forward in bioactive nutrition.
The Synergy of HMOs and Lactoferrin
Perhaps the most captivating facet of this science lies in the combination of HMOs and lactoferrin. In breast milk, these two bioactives work in unison, functioning as part of an integrated system designed to nurture and safeguard the infant gut. Researchers are now beginning to uncover that this synergy may also offer substantial benefits for adult health.
Consider how their action complements each other. HMOs selectively nourish beneficial Bifidobacterium species, promoting a microbiome that suppresses harmful organisms. Concurrently, lactoferrin provides a direct attack against pathogens, bolsters the gut barrier, and fine-tunes immune responses. Together, they tackle gut health from multiple dimensions: the microbiome, gut barrier, and immune system (Wiertsema et al., 2021).
This multifaceted approach markedly differs from simply taking a single-strain probiotic or a basic prebiotic fiber. Instead of introducing external bacteria that may struggle to survive their passage through the digestive tract, this method cooperates with the body’s own biology, enhancing the beneficial bacteria already present while simultaneously strengthening the natural defenses of the gut.
From Lab Research to Everyday Use
Historically, accessibility has been an obstacle. HMOs are intricate molecules that are challenging and costly to produce, and human-equivalent lactoferrin has not been an available ingredient for supplementation. However, that situation has now evolved.
Thanks to advancements in precision fermentation and biotechnology, it is now possible to produce both HMOs and recombinant human lactoferrin (effera™) on a large scale, paving the way for innovative supplement combinations. One company at the forefront of this movement is kēpos, which has developed the first supplement to merge HMOs with human-identical lactoferrin specifically for adult gut wellness. By uniting these two bioactives within one daily formula, kēpos is making the protective benefits of breast milk accessible to adults for the first time.
If you’ve faced digestive issues, persistent bloating, or want to adopt a more scientifically informed approach to gut health, this innovation represents an entirely new category of supplementation, rooted not in fleeting trends but in extensive research into the most advanced nutritional system nature has ever conceived.
Key Takeaways
What do these revelations imply for your daily health regimen? Here are several essential points to reflect on:
- Not all prebiotics are equal. Traditional prebiotics like inulin and FOS nourish a wide variety of gut bacteria, while HMOs are highly selective, promoting beneficial Bifidobacterium species without feeding less desirable microbes.
- Gut health encompasses more than just bacteria. A truly holistic approach considers the microbiome, the intestinal barrier, and the immune system as interconnected. The HMOs and lactoferrin combination addresses all these aspects comprehensively.
- Source is crucial. Human-identical lactoferrin (like effera™) more accurately reflects what the body produces naturally compared to the bovine-derived versions that are prevalent in the market.
- The scientific foundation is robust. The benefits of HMOs and lactoferrin are supported by randomized controlled trials and peer-reviewed studies, rather than solely anecdotal evidence.
- Small shifts can lead to big results. Including targeted bioactives such as HMOs and lactoferrin in your regimen may enhance digestive comfort, bolster immune resilience, and promote sustained gut health.
The Future of Gut Health Has Arrived
We are at an extraordinary juncture in nutritional science. The bioactives that have safeguarded and nourished human infants for generations are now becoming available for adult applications. HMOs and lactoferrin signify not only a progression in gut health supplementation but also a return to biological fundamentals—supporting the body rather than overriding it.
As we further explore the intricacies of the gut microbiome, one truth stands out: the path forward in gut health is not about amplifying bacterial counts in supplements. Instead, it’s about equipping your body with the appropriate biological tools necessary for thriving. Remarkably, those tools have been present in breast milk all along.
References
- Elison S, Vigsnaes LK, Rindom Krogsgaard L, et al. Oral supplementation of healthy adults with 2’-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr. 2016;116(8):1356–1368.
- Šuligoj T, Vigsnæs LK, Van den Abbeele P, et al. Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function. Nutrients. 2020;12(9):2808.
- Schalich KM, Buber MT, Engstrom M, et al. A human milk oligosaccharide prevents intestinal inflammation in adulthood. mBio. 2024;15(4):e00298-24.
- Legrand D. Overview of Lactoferrin as a Natural Immune Modulator. J Pediatr. 2016;173 Suppl:S10–S15.
- Ochoa TJ, Sizonenko SV. Lactoferrin and prematurity: a promising milk protein? Biochem Cell Biol. 2017;95(1):22–30.
- Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. Nutrients. 2021;13(3):886.
Author Bio
The science team at kēpos is passionate about advancing the understanding and utilization of human milk bioactives for adult well-being. Building on the latest peer-reviewed literature, kēpos has launched the first supplement that combines Human Milk Oligosaccharides (HMOs) with human-identical lactoferrin (effera™), making the protective elements of breast milk available to adults. Discover more at trykepos.com.
About The Author
